查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571792

肾造口设备市场规模、份额、趋势分析报告：依产品、最终用途、按地区、细分市场预测，2024-2030 年

Nephrostomy Devices Market Size, Share & Trends Analysis Report By Product (Guidewires, Drainage Tubes, Nephrostomy Catheters, Sheath Dilators), By End Use (Hospitals), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

肾造口设备市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球肾造口设备市场规模将达23.2亿美元，2024年至2030年复合年增长率为7.9%。

医生对肾造口设备的认识不断提高，肾结石病例数量不断增加，正在推动市场的发展。卵巢、膀胱癌和前列腺癌盛行率的增加以及新兴经济体医疗基础设施的改善也是推动市场成长的主要因素。

由于肾结石疾病以及卵巢、膀胱癌和前列腺癌的盛行率不断增加，北美预计将创下最高的市场占有率。例如，根据美国癌症协会的数据，2018 年美国大约诊断出 22,240 例卵巢癌新病例。该市场的主要企业专注于新产品的发布和现有产品的创新。例如，2017年2月，库克医疗推出了Universa，拥有两套经皮泌尿装置。

肾造口设备市场报告亮点

  • 导管导引线占据市场主导地位，2023 年市场占有率为 28.7%。这是由于老年人口的增加、医院基础设施的改善以及技术的进步。
  • 预计肾造口导管在预测期内将以显着的复合年增长率成长。这是由于男性和女性肾结石和尿道感染的增加。
  • 医院占据市场主导地位，2023年市场占有率为69.3%。医院通常可以获得肾造口技术的最新创新。
  • 2023 年，北美肾造口设备市场占据主导地位。这是由于该地区慢性肾臟病的盛行率不断上升。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章 肾造口设备市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 肾造口设备市场分析工具
    • 波特的分析
    • PESTEL分析

第四章 肾臟造口设备市场：产品估算与趋势分析

  • 细分仪表板
  • 肾造口设备市场：2023 年及 2030 年产品变化分析
  • 导管导引线
  • 引流管
  • 肾造口导管
  • 鞘套管扩张器
  • 其他的

第五章 肾臟造口设备市场：最终用途估计与趋势分析

  • 细分仪表板
  • 肾造口设备市场：2023 年和 2030 年最终用途变化分析
  • 医院
  • 急诊室
  • 日间手术中心 (ASC)

第六章肾臟造口设备市场：区域估计与趋势分析

  • 2023 年及 2030 年肾臟造口设备市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Boston Scientific Corporation
    • Teleflex Incorporated.
    • Cardinal Health.
    • BD
    • Cook Medical
    • B. Braun Melsungen AG
    • Coloplast Group
    • Olympus Corporation
    • Argon Medical Devices.
    • UreSil, LLC
简介目录
Product Code: GVR-3-68038-116-0

Nephrostomy Devices Market Growth & Trends:

The global nephrostomy devices market size is anticipated to reach USD 2.32 billion by 2030 registering a CAGR of 7.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing awareness about nephrostomy devices among physicians and rising cases of kidney stone disease are driving the market. Increasing prevalence of ovarian, bladder, and prostate cancers and improving healthcare infrastructure in the developing economies are also among the key factors fueling the market growth.

North America is expected to register the highest market share owing to increasing prevalence of kidney stone disorder and ovarian, bladder, and prostate cancers. For instance, according to the American Cancer Society, around 22,240 new cases of ovarian cancer were diagnosed in 2018 in U.S. Major companies in this market are emphasizing on new product launches and innovations in the existing products. For instance, in February 2017, Cook Medical introduced Universa along with the two sets of percutaneous urinary drainage.

Nephrostomy Devices Market Report Highlights:

  • Guidewires dominated the market and accounted for a market share of 28.7% in 2023. It can be attributed to the rising geriatric population, improved hospital infrastructure, and technological advancements.
  • Nephrostomy catheters are expected to grow at a significant CAGR over the forecast period. It can be attributed to the rising cases of kidney stones & urinary tract infections in both men and women.
  • Hospitals dominated the market and accounted for a market share of 69.3% in 2023. Hospitals typically have access to the latest innovations in nephrostomy technology.
  • North America nephrostomy devices market dominated in 2023. It can be attributed to the increasing prevalence of chronic kidney diseases in the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Nephrostomy Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Nephrostomy Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Nephrostomy Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Nephrostomy Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Guidewires
    • 4.3.1. Guidewires Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Drainage Tubes
    • 4.4.1. Drainage Tubes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Nephrostomy Catheters
    • 4.5.1. Nephrostomy Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Sheath Dilators
    • 4.6.1. Sheath Dilators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Nephrostomy Devices Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Nephrostomy Devices Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Hospitals
    • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Emergency Clinics
    • 5.4.1. Emergency Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Ambulatory Surgical Centers (ASCs)
    • 5.5.1. Ambulatory Surgical Centers (ASCs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Nephrostomy Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Nephrostomy Devices Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Sweden Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. South Korea Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Nephrostomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Boston Scientific Corporation
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Teleflex Incorporated.
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Cardinal Health.
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. BD
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Cook Medical
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. B. Braun Melsungen AG
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Coloplast Group
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Olympus Corporation
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Argon Medical Devices.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. UreSil, LLC
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives